Carcinoembryonic antigen in women with isolated pelvic masses: Clinical utility?

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 5, 1998, Pages 403-407

  Roman, Lynda D ^a   Muderspach, Laila I ^a   Burnett, Alexander F ^a   Paul Morrow, C ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

CA 125 antigen; Carcinoembryonic antigen; Pelvic neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PELVIS TUMOR; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0031749018     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-462
2. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467-481
3. Thomson DMP, Krupey J, Freedman SO, et al: The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 1969;64: 161-167
4. Mendelsohn J: Principles of neoplasia. In Harrison's Principles of Internal Medicine. Edited by E Braunwald, KJ Isselbacher, RG Petersdorf, et al. Eleventh edition. New York, McGraw-Hill, 1987, p 421-431
5. Corman ML: Carcinoma of the Colon. In Colon and Rectal Surgery. Edited by ML Corman. Philadelphia, JB Lippincott, 1989, p 387-468
6. DiSaia PJ, Haverback B, Dyce BJ, et al: Carcinoembryonic antigen in patients with gynecologic malignancies. Am J Obstet Gynecol 1975;121:159-163
7. Roman LD, Muderspach LI, Stein SM, et al: Pelvic examination, tumor marker level and gray-scale and doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 1997;89:493-500
8. Malkasian GD Jr, Knapp RC, Lavin PT, et al: Preoperative evaluation of serum CA-125 levels in premenopausal and posrmenopausal patients with pelvic masses: Discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341-346
9. Finkler NJ, Benacerraf B, Lavin PT, et al: Comparison of serum CA 125, clinical impression, and ultrasound in the preoperarive evaluation of ovarian masses. Obstet Gynecol 1988;72:659-664
10. Vasilev SA, Schlaerth JB, Campeau J, et al: Serum CA 125 levels in preoperarive evaluation of pelvic masses. Obstet Gynecol 1988;71:751-756
11. Jacobs I, Oram D, Fairbanks J, et al: A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97:922-929
12. Patsner B, Mann WJ: The value of preoperative serum CA 125 levels in patients with a pelvic mass. Am J Obstet Gynecol 1988;159:873-876
13. O'Connell GJ, Ryan E, Murphy KJ, et al: Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses. Obstet Gynecol 1987;70:930-932
14. Di-Xia C, Schwartz PE, Xinguo L, et al: Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol 1988;72:23-27
15. Weiner Z, Thaler I, Beck D, et al: Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol 1992;79:159-162
16. Gadducci A, Cariello P, Bartolini T, et al: The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinoma. Eur J Gynaecol Oncol 1988; 5:373-376
17. Strigini FAL, Gadducci A, DelBravo B, et al: Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre-and postmenopausal women. Gynecol Oncol 1996;61:68-72
18. Kurjak A, Predanic M: New scoring system for prediction of ovarian malignancy based on transvaginal color doppler sonography. J Ultrasound Med 1992;11:631-638
19. Bromley B, Goodman H, Benacerraf BR: Comparison between sonography morphology and doppler waveform for the diagnosis of ovarian malignancy. Obstet Gynecol 1994; 83:434-437
20. Jain KA, Friedman DL, Pettinger TW, et al: Adnexal masses: Comparison of specificity of endovaginal US and pelvic MR imaging. Radiology 1993;186:697-704
21. Granberg S, Norstrom A, Wikland M: Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 1990;37:224-229
22. Sassone AM, Timor-Tritsch IE, Artner A, et al: Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991;78:70-76
23. Luxman D, Bergman A, Sagi J, et al: The postmenopausal adnexal mass: Correlation between ultrasonic and pathologic findings. Obstet Gynecol 1991;77:726-727
24. Hata K, Hata T, Manabe A, et al: A critical evaluation of transvaginal doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer. Obstet Gynecol 1992;80:922-926
25. DePriest PD, Varner E, Powell J, et al: The efficacy of a sonographic morphology index in identifying ovarian cancer: A multi-institutional investigation. Gynecol Oncol 1994;55: 174-178
26. Schneider VL, Schneider A, Reed KL, et al: Comparison of doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses. Obstet Gynecol 1993;81:983-988
27. Valentin L, Sladkevicius P, Marsal K: Limited contribution of doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994;83:425-433
28. Kurjak A, Zalud I, Alfirevic Z: Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 1991;10:295-297
29. Fleischer AC, Cullinan JA, Kepple DM, et al: Conventional and color doppler transvaginal sonography of pelvic masses: A comparison of relative histologie specificities. J Ultrasound Med 1993;12:705-712
30. Kurjak A, Schulman H, Sosic A, et al: Transvaginal ultrasound, color flow, and doppler waveform of the postmenopausal adnexal mass. Obstet Gynecol 1992;80:917-921
31. Kawai M, Kano T, Kikkawa F, et al: Transvaginal doppler ultrasound with color flow imaging in the diagnosis of ovarian cancer. Obstet Gynecol 1992;79:163-167
32. Williams SD, Gershenson DM, Horowitz CJ, et al: Ovarian germ cell and stromal tumors. In Principles and Practice of Gynecologic Oncology. Edited by WJ Hoskins, CA Perez, RC Young. Philadelphia, JB Lippincott, 1992, pp 715-730
33. Schwartz PE, Morris JM: Serum lactic dehydrogenase: A tumor marker for dysgerminoma. Obstet Gynecol 1988;72:511-515
34. Tamakoshi K, Kikkawa F, Shibata K, et al: Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Gynecol Oncol 1996;62:67-72
35. Stall KE, Martin EW: Plasma carcinoembryonic antigen levels in ovarian cancer patients, A chart review and survey of published data. J Reprod Med 1981;26:73-79